{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:05:25Z","timestamp":1793387125024,"version":"4.5.0"},"reference-count":255,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Liver cancers show high interindividual and intratumor heterogeneity. Among them, hepatocellular carcinoma (HCCs) represents approximately 90% of liver cancers, followed by intrahepatic cholangiocarcinoma (iCCA; ~10 to 15%), childhood hepatoblastoma, angiosarcoma and hemangioendothelioma (&amp;lt; 1%). More than 80% of HCCs arise in a backdrop of chronic inflammatory liver diseases of diverse etiologies. These underlying liver diseases are major determinants of geographic diversity of HCCs. Across the world, substantial differences in the prevalence of chronic viral hepatitides, alcohol misuse, Metabolic Disfunction-Associated Steatotic Liver Disease (MASLD) and exposure to toxic substances are frequently related to social and economic inequalities. Vulnerable populations are more frequently exposed to infections such as hepatitis B and C viruses that, combined with other risk factors, lead to both vertical and horizontal transmission and, in turn, impact on age and sex-related diversity. In this review, we describe the global landscape of risk factors leading to HCC: MASLD, chronic hepatitis B and C infections, alcohol misuse, exposure to other toxic substances and genetic predispositions. We describe their combined effects on the clinical and epidemiological features of HCCs around the globe. Clinical presentation, incidence and mortality rates of HCCs show therefore great geographic heterogeneity, which is also related to the inequalities in the gross domestic product <jats:italic>per capita<\/jats:italic>, the socio-demographic index, the access to health care resources and to the implementation of policies for surveillance and screening of patients at risk. Awareness of the biological and geopolitical sources of HCC diversity will hopefully lead to more efficient international cooperation in the prevention and early management of chronic liver diseases and HCC.<\/jats:p>","DOI":"10.3389\/fonc.2025.1565692","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:18Z","timestamp":1747368678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Geographic diversity of human liver cancers mirrors global social inequalities"],"prefix":"10.3389","volume":"15","author":[{"given":"Luis","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: A review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: The growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000443","article-title":"Matrisomic characterization of HCC to inform individualized patient management","volume":"78","author":"Kanzaki","year":"2023","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29254","article-title":"Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection","volume":"66","author":"D\u00e9sert","year":"2017","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000362","article-title":"Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT\/TGFB signatures, associated with poor outcome","volume":"78","author":"Desert","year":"2023","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v156.7","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12916-018-1039-1","article-title":"Performance of InSilicoVA for assigning causes of death to verbal autopsies: multisite validation study using clinical diagnostic gold standards","volume":"16","author":"Flaxman","year":"2018","journal-title":"BMC Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12916-020-01518-9","article-title":"Non-confirming replication of \u201cPerformance of InSilicoVA for assigning causes of death to verbal autopsies: multisite validation study using clinical diagnostic gold standards,\u201d by Flaxman et\u00a0al","volume":"18","author":"Li","year":"2020","journal-title":"BMC Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.1568","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PloS Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2020.10.005","article-title":"Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and Malignant progression","volume":"149","author":"Sirica","year":"2021","journal-title":"Adv Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"B22","article-title":"Analysis and comparative review of equality data collection practices in the European Union: data collection in the field of ethnicity","author":"Farkas","year":"2017"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15388\/OS.LAW.2020.11","article-title":"Combating discrimination through Big Data \u2013 future of equality","volume":"6","author":"Sakolciov\u00e1","year":"2020","journal-title":"Vilnius Univ Open Ser"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.12.001","article-title":"Genetic diversity and association studies in US Hispanic\/Latino populations: applications in the hispanic community health study\/study of Latinos","volume":"98","author":"Conomos","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/13691830500178147","article-title":"Immigrants and associations: A global and historical perspective","volume":"31","author":"Moya","year":"2005","journal-title":"J Ethics Migration Stud"},{"key":"B26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2468-1253(19)30188-8","article-title":"Hepatobiliary cancers in South America: disparity strikes","volume":"4","author":"Debes","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16578","article-title":"Impact of self-reported ancestry on the epidemiology of hepatocellular carcinoma","volume":"39","author":"Loon","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"B28","first-page":"16","article-title":"Immigration past & Present","volume-title":"Daedalus, Immigration & the Future of America","author":"Foner","year":"2013"},{"key":"B29","first-page":"273","article-title":"Slavery as immigration","volume":"44","author":"Magee","year":"2010","journal-title":"Univ San Franc Law Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","article-title":"Incidence of etiology-specific hepatocellular carcinoma: diverging trends and significant heterogeneity by race and ethnicity","volume":"22","author":"Pinheiro","year":"2024","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.2208","article-title":"Liver cancer etiology in Asian subgroups and American Indian, black, Latino, and white populations","volume":"8","author":"Pinheiro","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/HEP.0000000000000909","article-title":"Liver cancer in young adults: Validity of global data sets","volume":"80","author":"La Vecchia","year":"2024","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30750-9","article-title":"Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Lozano","year":"2020","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-023-00109-0","article-title":"Global, regional, and national trends in incidence and mortality of primary liver cancer and its underlying etiologies from 1990 to 2019: results from the global burden of disease study 2019","volume":"13","author":"Cao","year":"2023","journal-title":"J Epidemiol Glob Health"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad067","article-title":"Association of nativity with survival among adults with hepatocellular carcinoma","volume":"115","author":"Zhou","year":"2023","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djac078","article-title":"Cancer mortality patterns by birthplace and generation status of Mexican Latinos: the multiethnic cohort","volume":"114","author":"Chen","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v130.2","article-title":"Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort","volume":"130","author":"Acuna","year":"2024","journal-title":"Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08998280.2024.2406030","article-title":"Exploring social determinants and hepatocellular carcinoma: a scoping review of evidence and implications","volume":"38","author":"Escobar Gil","year":"2025","journal-title":"Bayl Univ Med Cent Proc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/jca.19922","article-title":"Lower education and household income contribute to advanced disease, less treatment received and poorer prognosis in patients with hepatocellular carcinoma","volume":"8","author":"Shen","year":"2017","journal-title":"J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000428","article-title":"Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors","volume":"27","author":"Baecker","year":"2018","journal-title":"Eur J Cancer Prev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15784","article-title":"Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016","volume":"44","author":"Comoz","year":"2024","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00279-5","article-title":"Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study","volume":"22","author":"Rumgay","year":"2021","journal-title":"Lancet Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a008408","article-title":"Meta-analysis of alcohol intake in relation to risk of liver cirrhosis","volume":"33","author":"Corrao","year":"1998","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"B46","first-page":"3","article-title":"Alcohol consumption and ethyl carbamate","volume":"96","year":"2010","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Ganne-Carri\u00e9","year":"2019","journal-title":"J Hepatol"},{"key":"B48","unstructured":"Global Status Report on Alcohol and Health 2018"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.12.030","article-title":"Differences between hepatocellular carcinoma caused by alcohol and other aetiologies","volume":"82","author":"Ganne-Carri\u00e9","year":"2024","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.cgh.2024.06.026","article-title":"Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma","volume":"22","author":"Zeng","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.11.006","article-title":"Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes","volume":"80","author":"D\u00edaz","year":"2024","journal-title":"J Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00107-5","article-title":"Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France","volume":"9","author":"Schwarzinger","year":"2024","journal-title":"Lancet Public Health"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.10.010","article-title":"Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms","volume":"21","author":"Kelly","year":"2010","journal-title":"Int J Drug Policy"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00124-5","article-title":"Alcohol in France: room for improvement","volume":"9","author":"Hill","year":"2024","journal-title":"Lancet Public Health"},{"key":"B55","article-title":"Screening, diagnosis, and treatment of alcohol-related liver disease and alcohol-associated hepatitis","volume":"18","author":"Patel","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B58","article-title":"Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries","volume":"15","author":"Seyda Seydel","year":"2016","journal-title":"Ann Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41467-017-01358-x","article-title":"Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis","volume":"8","author":"Letouz\u00e9","year":"2017","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt335","article-title":"The 2014 Surgeon General\u2019s report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking","volume":"179","author":"Alberg","year":"2014","journal-title":"Am J Epidemiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0007-z","article-title":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project","volume":"118","author":"Petrick","year":"2018","journal-title":"Br J Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.07.016","article-title":"Tobacco, cigarettes, and the liver: the smoking gun","volume":"11","author":"Premkumar","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0901388","article-title":"Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment","volume":"118","author":"Liu","year":"2010","journal-title":"Environ Health Perspect"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/ijerph17041215","article-title":"Aflatoxins: producing-molds, structure, health issues and incidence in Southeast Asian and Sub-Saharan African countries","volume":"17","author":"Benkerroum","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B65","article-title":"Aflatoxin B1 content in patients with hepatic diseases","volume":"62","author":"L\u00f3pez","year":"2002","journal-title":"Medicina (Mex)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/ol.2013.1169","article-title":"Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention","volume":"5","author":"Hamid","year":"2013","journal-title":"Oncol Lett"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0315561","article-title":"Associations between dietary mycotoxins exposures and risk of hepatocellular carcinoma in a European cohort","volume":"19","author":"Huybrechts","year":"2024","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.2019.44.issue-2","article-title":"Recognition of the toxicity of aristolochic acid","volume":"44","author":"Zhang","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0219","article-title":"Aristolochic acid in the etiology of renal cell carcinoma","volume":"25","author":"Hoang","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan6446","article-title":"Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia","volume":"9","author":"Ng","year":"2017","journal-title":"Sci Transl Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30863","article-title":"The mutational features of aristolochic acid-induced mouse and human liver cancers","volume":"71","author":"Lu","year":"2020","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int"},{"key":"B74","article-title":"p53 gene mutation pattern in rat liver tumors induced by vinyl chloride","volume":"57","author":"Barbin","year":"1997","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-017-0611-y","article-title":"Carcinogens that induce the A:T > T:A nucleotide substitutions in the genome","volume":"12","author":"Zhou","year":"2018","journal-title":"Front Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2007.02.021","article-title":"Hepatitis B virus genetic variability and evolution","volume":"127","author":"Kay","year":"2007","journal-title":"Virus Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-2-82","article-title":"Hepatitis B virus: inactive carriers","volume":"2","author":"Sharma","year":"2005","journal-title":"Virol J"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-induced immune imbalance in the development of HCC","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol eCollection"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i42.11941","article-title":"Hepatitis B virus burden in developing countries","volume":"21","author":"Zampino","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200411003-00008","article-title":"Global epidemiology of hepatitis B virus","volume":"38","author":"Custer","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003068","article-title":"Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis","volume":"17","author":"McNaughton","year":"2020","journal-title":"PloS Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12879-019-4731-7","article-title":"The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey","volume":"20","author":"Lingani","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015298","article-title":"Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis","volume":"7","author":"Bigna","year":"2017","journal-title":"BMJ Open"},{"key":"B85","article-title":"Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria","volume":"6","author":"Ugwuja","year":"2010","journal-title":"Internet J Trop Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1992.47.357","article-title":"The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions","volume":"47","author":"Bile","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1872-034X.2007.00098.x","article-title":"Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes","volume":"37","author":"Kramvis","year":"2007","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clinre.2014.06.005","article-title":"Epidemiology of HBV subgenotypes D","volume":"39","author":"Ozaras","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000323524","article-title":"Characterization of hepatitis B virus molecular genotypes in Chongqing and quantitative serological markers in patients during natural phases of chronic hepatitis B infection","volume":"55","author":"Xiang","year":"2012","journal-title":"Intervirology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81614-0","article-title":"Phylogenetic analysis of the precore\/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations","volume":"87","author":"Olinger","year":"2006","journal-title":"J Gen Virol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jcv.2013.06.028","article-title":"Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries","volume":"58","author":"Forbi","year":"2013","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.10.009","article-title":"Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period","volume":"16","author":"Luo","year":"2012","journal-title":"Int J Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14218\/JCTH.2013.00030","article-title":"Epidemiology of hepatitis B virus infection in China: current status and challenges","volume":"2","author":"Yan","year":"2014","journal-title":"J Clin Transl Hepatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","article-title":"Hepatitis B infection in the general population of China: a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.007","article-title":"The epidemiology of hepatitis B virus infection in Korea","volume":"34","author":"Yim","year":"2019","journal-title":"Korean J Intern Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1240","article-title":"Viral hepatitis in South Korea","volume":"7","author":"Pak S","year":"2017","journal-title":"Euroasian J Hepato-Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-009-0246-3","article-title":"Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis","volume":"76","author":"Batham","year":"2009","journal-title":"Indian J Pediatr"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2017.00024","article-title":"Current scenario of hepatitis B and its treatment in India","volume":"5","author":"Ray","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajg.2013.04.002","article-title":"Hepatitis B virus in the Arab world: where do we stand","volume":"14","author":"Gasim","year":"2013","journal-title":"Arab J Gastroenterol Off Publ Pan-Arab Assoc Gastroenterol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2595","article-title":"Epidemiological update of hepatitis B, C and delta in Latin America","volume":"18","author":"Alvarado-Mora","year":"2013","journal-title":"Antivir Ther"},{"key":"B102","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.3748\/wjg.v20.i23.7181","article-title":"Hepatitis B virus infection in Latin America: A genomic medicine approach","volume":"20","author":"Roman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.aogh.2014.09.013","article-title":"Infection and cancer: global distribution and burden of diseases","volume":"80","author":"Oh","year":"2014","journal-title":"Ann Glob Health"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92876-6","article-title":"Horizontal transmission of hepatitis B virus","volume":"1","author":"Davis","year":"1989","journal-title":"Lancet Lond Engl"},{"key":"B105","article-title":"Hiperendemicidad de Hepatitis Viral B y Delta en pueblos indigenas de la Amazon\u00eda Peruana","volume":"23","author":"Cabezas","year":"2006","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.t01-1-07641.x","article-title":"Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status","volume":"98","author":"Di Bisceglie","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071115","article-title":"Prevalence and modes of transmission of hepatitis C virus infection: A historical worldwide review","volume":"16","author":"Stroffolini","year":"2024","journal-title":"Viruses"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000204","article-title":"Prior to the oral therapy, what do we know about HCV-4 in Egypt: A randomized survey of prevalence and risks using data mining computed analysis","volume":"93","author":"Abd Elrazek","year":"2014","journal-title":"Med (Baltimore)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.2016.23.issue-4","article-title":"Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis","volume":"23","author":"Riou","year":"2016","journal-title":"J Viral Hepat"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02387.x","article-title":"Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors","volume":"50","author":"Tserenpuntsag","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.26719\/2018.24.6.595","article-title":"Blood transfusion and hepatitis: what does it take to prevent new infections","volume":"24","author":"Abdella","year":"2018","journal-title":"East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit"},{"key":"B117","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.coviro.2016.09.010","article-title":"Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma","volume":"20","author":"Bandiera","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-1000-9","article-title":"MICA SNPs and the NKG2D system in virus-induced HCC","volume":"50","author":"Goto","year":"2015","journal-title":"J Gastroenterol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.032","article-title":"Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma","volume":"59","author":"Lange","year":"2013","journal-title":"J Hepatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat Genet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2013.09.025","article-title":"Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma","volume":"146","author":"Ikeda","year":"2014","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.10.035","article-title":"A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection","volume":"13","author":"Chang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9245","article-title":"Polymorphisms in the IFNL3\/IL28B gene and hepatitis C: From adults to children","volume":"20","author":"Indolfi","year":"2014","journal-title":"World J Gastroenterol WJG"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.2.105","article-title":"Hepatitis C virus-induced hepatocellular carcinoma","volume":"21","author":"Goossens","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.01.019","article-title":"Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis","volume":"50","author":"Raimondi","year":"2009","journal-title":"J Hepatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.016","article-title":"Management of hepatitis C virus genotype 4: recommendations of an international expert panel","volume":"54","author":"Khattab","year":"2011","journal-title":"J Hepatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.123","article-title":"HCV genotype 6 increased the risk for hepatocellular carcinoma among Asian patients with liver cirrhosis","volume":"112","author":"Lee","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cgh.2023.06.026","article-title":"Regional differences in clinical presentation and prognosis of patients with post\u2013sustained virologic response hepatocellular carcinoma","volume":"22","author":"Toyoda","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0702","article-title":"Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy","volume":"15","author":"Franceschi","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B131","first-page":"1379","volume-title":"Robbins & Cotran pathologic basis of disease","author":"Kumar","year":"2021"},{"key":"B132","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1424155","article-title":"Worldwide burden of liver cancer due to metabolic dysfunction-associated steatohepatitis from 1990 to 2019: insights from the Global Burden of Disease study","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"100936","DOI":"10.1016\/j.jhepr.2023.100936","article-title":"SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH","volume":"6","author":"Cano","year":"2024","journal-title":"JHEP Rep"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.11.026","article-title":"Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment","volume":"1864","author":"Agosti","year":"2018","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27353","article-title":"Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells","volume":"60","author":"Dubois-Pot-Schneider","year":"2014","journal-title":"Hepatology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.06.052","article-title":"Regulation of transdifferentiation and retrodifferentiation by inflammatory cytokines in hepatocellular carcinoma","volume":"151","author":"Cabillic","year":"2016","journal-title":"Gastroenterology"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v11.5","article-title":"Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12036","article-title":"Epidemiology of alcoholic and nonalcoholic fatty liver disease in China","author":"Fan","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J Gastroenterol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2013.19.3.266","article-title":"Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea","volume":"19","author":"Jeong","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","article-title":"The changing epidemiology of liver diseases in the Asia-Pacific region","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20033","article-title":"Obesity and diabetes as a risk factor for hepatocellular carcinoma","volume":"10","author":"Regimbeau","year":"2004","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: A review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/liv.v40.s1","article-title":"Natural history of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J Med Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000810","article-title":"Recent trends in the epidemiology of hepatocellular carcinoma in olmsted county, minnesota: A US population-based study","volume":"51","author":"Yang","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: A systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v122.11","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Makarova-Rusher","year":"2016","journal-title":"Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1111\/liv.2015.35.issue-9","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.289","article-title":"Hepatocellular carcinoma occurs at an earlier age in africans, particularly in association with chronic hepatitis B","volume":"110","author":"Yang","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067756","article-title":"An atypical age-specific pattern of hepatocellular carcinoma in Peru: A threat for Andean populations","volume":"8","author":"Bertani","year":"2013","journal-title":"PloS One"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v123.1","article-title":"Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States","volume":"123","author":"Yang","year":"2017","journal-title":"Cancer"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.03.007","article-title":"Hepatitis C virus screening trends: A 2016 update of the National Health Interview Survey","volume":"60","author":"Kasting","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-5331-x","article-title":"Comparison of hepatocellular carcinoma in patients with cryptogenic versus hepatitis B etiology: A study of 1079 cases over 3 decades","volume":"64","author":"Liew","year":"2019","journal-title":"Dig Dis Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.661988","article-title":"Identification of aging-related genes associated with clinical and prognostic features of hepatocellular carcinoma","volume":"12","author":"Chen","year":"2021","journal-title":"Front Genet"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.052","article-title":"Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target","volume":"74","author":"Ningarhari","year":"2021","journal-title":"J Hepatol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/HEP.0000000000000872","article-title":"Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019","volume":"80","author":"Danpanichkul","year":"2024","journal-title":"Hepatology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in myD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.004","article-title":"Why men are at higher risk for hepatocellular carcinoma","volume":"57","author":"Keng","year":"2012","journal-title":"J Hepatol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"102498","DOI":"10.1016\/j.clinre.2024.102498","article-title":"Prolonged survival in women with hepatocellular carcinoma: A French observational study","volume":"48","author":"Busso","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i36.6674","article-title":"Genetic biomarkers for hepatocellular cancer risk in a caucasian population","volume":"23","author":"De Mattia","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jhep.2020.01.019","article-title":"The landscape of gene mutations in cirrhosis and hepatocellular carcinoma","volume":"72","author":"M\u00fcller","year":"2020","journal-title":"J Hepatol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.02.005","article-title":"Clinical utility of polygenic risk scores for predicting NAFLD disorders","volume":"74","author":"Dessein","year":"2021","journal-title":"J Hepatol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J Hepatol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00603-3","article-title":"Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study","volume":"23","author":"Tr\u00e9po","year":"2022","journal-title":"Lancet Oncol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29498","article-title":"Projections of primary liver cancer to 2030 in 30 countries worldwide","volume":"67","author":"Valery","year":"2018","journal-title":"Hepatology"},{"key":"B188","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3978\/j.issn.2304-3865.2013.09.07","article-title":"Features and treatment options of Chinese hepatocellular carcinoma","volume":"2","author":"Wu","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20100190","article-title":"Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures","volume":"21","author":"Tanaka","year":"2011","journal-title":"J Epidemiol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"20922","DOI":"10.1038\/s41598-020-77515-y","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"key":"B192","article-title":"Hong Kong Cancer Registry","volume-title":"Report of Stage-specific Survival of Liver Cancer in Hong Kong","year":""},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03029.x","article-title":"Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong","volume":"24","author":"Cheung","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00731.x","article-title":"Report of the 18th follow-up survey of primary liver cancer in Japan","volume":"40","author":"Ikai","year":"2010","journal-title":"Hepatol Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05784.x","article-title":"Hepatocellular carcinoma in the Asia pacific region","volume":"24","author":"Yuen","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"B196","first-page":"97","article-title":"Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India","volume":"9","author":"Yeole","year":"2008","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"B197","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","article-title":"Global epidemiology of hepatocellular carcinoma","volume":"15","author":"Singh","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"B198","article-title":"Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India","volume":"26","author":"Paul","year":"2007","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM Int J Med"},{"key":"B200","doi-asserted-by":"publisher","first-page":"153290","DOI":"10.1016\/j.prp.2020.153290","article-title":"Hepatocellular carcinoma: Clinicopathologic associations amidst marked phenotypic heterogeneity","volume":"217","author":"Rastogi","year":"2021","journal-title":"Pathol - Res Pract"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1177","article-title":"Epidemiology of liver diseases in India","volume":"19","author":"Mondal","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B202","volume-title":"Global Cancer Observatory: Cancer Today (version 1.1)","author":"Ferlay","year":"2024"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2007.00091.x","article-title":"Hepatocellular carcinoma in Filipinos","volume":"3","author":"Wong","year":"2007","journal-title":"Asia Pac J Clin Oncol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.130","article-title":"Demographic profile and treatment outcomes of Filipino patients with hepatocellular carcinoma in a liver tumor registry","volume":"13","author":"Carpio","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3860\/pjim.v47i1.877","article-title":"The clinical profile of hepatocellular carcinoma patients at the Philippine general hospital","volume":"47","author":"Lucas","year":"2009","journal-title":"Philipp J Intern Med"},{"key":"B206","article-title":"High prevalence of hepatocellular carcinoma in patients with chronic hepatitis B infection in Thailand","volume":"17","author":"Wanich","year":"2016","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0281","article-title":"Cancer in Africa 2012","volume":"23","author":"Parkin","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i27.3038","article-title":"Systematic overview of hepatitis C infection in the Middle East and North Africa","volume":"24","author":"Chaabna","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3399566","article-title":"Epidemiology of liver cancer in Africa: current and future trends","volume":"40","author":"Okeke","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B210","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4254\/wjh.v3.i1.24","article-title":"First multicenter study for risk factors for hepatocellular carcinoma development in North Africa","volume":"3","author":"Bahri","year":"2011","journal-title":"World J Hepatol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00042-5","article-title":"Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions","volume":"7","author":"Jonas","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.22.11770-11774.2002","article-title":"Altered DNA mutation spectrum in aflatoxin B1-treated transgenic mice that express the hepatitis B virus X protein","volume":"76","author":"Madden","year":"2002","journal-title":"J Virol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/liv.2015.35.issue-3","article-title":"The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure","volume":"35","author":"Qi","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/79.5.1124","article-title":"Aflatoxin B1 in common Egyptian foods","volume":"79","author":"Selim","year":"1996","journal-title":"J AOAC Int"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.13-0563","article-title":"An overview on mycotoxin contamination of foods in Africa","volume":"76","author":"Darwish","year":"2014","journal-title":"J Vet Med Sci"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2008.01.008","article-title":"Mycotoxin problem in Africa: current status, implications to food safety and health and possible management strategies","volume":"124","author":"Wagacha","year":"2008","journal-title":"Int J Food Microbiol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(84)90038-3","article-title":"Aflatoxin contamination of Nigerian foods and feedingstuffs","volume":"32","author":"Atawodi","year":"1994","journal-title":"Food Chem Toxicol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(95)02111-6","article-title":"Iron-induced carcinogenesis: the role of redox regulation","volume":"20","author":"Toyokuni","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.5.727","article-title":"Hepatocellular carcinoma and African iron overload","volume":"37","author":"Gangaidzo","year":"1995","journal-title":"Gut"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01515.x","article-title":"Dietary iron overload in the African and hepatocellular carcinoma","volume":"27","author":"Kew","year":"2007","journal-title":"Liver Int"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270614","article-title":"Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans","volume":"27","author":"Mandishona","year":"1998","journal-title":"Hepatology"},{"key":"B223","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2008.11.001","article-title":"Hepatic iron overload and hepatocellular carcinoma","volume":"286","author":"Kew","year":"2009","journal-title":"Cancer Lett"},{"key":"B224","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000343856","article-title":"Hepatic iron overload and hepatocellular carcinoma","volume":"3","author":"Kew","year":"2014","journal-title":"Liver Cancer"},{"key":"B225","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.eclinm.2019.10.005","article-title":"Sub-Sahara Africa\u2014The impact and challenge of type 2 diabetes mellitus requiring urgent and sustainable public health measures","volume":"16","author":"Sinclair","year":"2019","journal-title":"EClinicalMedicine"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001574","article-title":"HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment","volume":"31","author":"Singh","year":"2017","journal-title":"AIDS Lond Engl"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30161-3","article-title":"Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium","volume":"2","author":"Yang","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31354-7","article-title":"Epidemiology of hepatocellular carcinoma in sub-Saharan Africa","volume":"12","author":"Kew","year":"2015","journal-title":"Ann Hepatol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-008-9526-8","article-title":"Malignant liver tumors in South African children: a national audit","volume":"32","author":"Moore","year":"2008","journal-title":"World J Surg"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.v3.2","article-title":"Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross-sectional study (2016-2017)","volume":"3","author":"Alvarez","year":"2020","journal-title":"Health Sci Rep"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.v5.1","article-title":"Associations between aflatoxin B1-albumin adduct levels with metabolic conditions in Guatemala: A cross-sectional study","volume":"5","author":"Alvarez","year":"2022","journal-title":"Health Sci Rep"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.015","article-title":"Early age hepatocellular carcinoma associated with hepatitis B infection in South America","volume":"15","author":"Chan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"100876","DOI":"10.1016\/j.aohep.2022.100876","article-title":"Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network","volume":"28","author":"Farah","year":"2023","journal-title":"Ann Hepatol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"12031","DOI":"10.1038\/s41598-018-30229-8","article-title":"Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden","volume":"8","author":"Marchio","year":"2018","journal-title":"Sci Rep"},{"key":"B235","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1038\/s41598-018-28286-0","article-title":"Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America","volume":"8","author":"Cano","year":"2018","journal-title":"Sci Rep"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2018.10.019","article-title":"On hepatocellular carcinoma in South America and early-age onset of the disease","volume":"43","author":"Pineau","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"14195","DOI":"10.1038\/s41598-021-93369-4","article-title":"Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cells","volume":"11","author":"Cano","year":"2021","journal-title":"Sci Rep"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09156-4","article-title":"Disparities in presentation at time of hepatocellular carcinoma diagnosis: A United States safety-net collaborative study","volume":"28","author":"Kronenfeld","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cgh.2018.05.039","article-title":"Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma","volume":"17","author":"Rich","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.12.029","article-title":"Racial and ethnic disparities in survival among patients with hepatocellular carcinoma in the United States: A systematic review and meta-analysis","volume":"20","author":"Rich","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2017.06.008","article-title":"Parcours de soins du patient atteint de carcinome h\u00e9patocellulaire en France: \u00e9tat des lieux en 2017","volume":"104","author":"Costentin","year":"2017","journal-title":"Bull Cancer (Paris)"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.015","article-title":"Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country","volume":"66","author":"Goutt\u00e9","year":"2017","journal-title":"J Hepatol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00580-8","article-title":"Achieving universal health coverage in France: policy reforms and the challenge of inequalities","volume":"387","author":"Nay","year":"2016","journal-title":"Lancet"},{"key":"B244","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.clinre.2023.102124","article-title":"Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis","volume":"47","author":"Mathurin","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u22642 cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1923","article-title":"Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies","volume":"6","author":"Reveron-Thornton","year":"2022","journal-title":"Hepatol Commun"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70343-1","article-title":"Improving access to analgesic drugs for patients with cancer in sub-Saharan Africa","volume":"14","author":"O\u2019Brien","year":"2013","journal-title":"Lancet Oncol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v6.i11.783","article-title":"Problem of hepatocellular carcinoma in West Africa","volume":"6","author":"Ladep","year":"2014","journal-title":"World J Hepatol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1159\/000507370","article-title":"A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-pacific primary liver cancer expert consensus statements","volume":"9","author":"Kudo","year":"2020","journal-title":"Liver Cancer"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i27.3607","article-title":"Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis","volume":"25","author":"Pi\u00f1ero","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.06.003","article-title":"Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma","volume":"19","author":"Pi\u00f1ero","year":"2020","journal-title":"Ann Hepatol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s0004-2803.202000000-20","article-title":"Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma","volume":"57","author":"Chagas","year":"2020","journal-title":"Arq Gastroenterol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.aohep.2021.100344","article-title":"Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice","volume":"25","author":"Dirchwolf","year":"2021","journal-title":"Ann Hepatol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.005","article-title":"Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisions","volume":"79","author":"Innes","year":"2023","journal-title":"J Hepatol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.031","article-title":"Inequities in primary liver cancer in Europe: The state of play","volume":"80","author":"Kondili","year":"2024","journal-title":"J Hepatol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1565692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:28Z","timestamp":1747368688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1565692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":255,"alternative-id":["10.3389\/fonc.2025.1565692"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1565692","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"article-number":"1565692"}}